Harnessing the Microbiome for Drug Discovery: the Example of a Microbiome-Derived Therapeutic for Ulcerative Colitis

Time: 11:45 am
day: Day 2 - Track B Afternoon

Details:

  • Microbiome-derived IL-10 inducer on specific bioassays
  • Characterization and preclinical validation of EB1010
  • Intended clinical development of EB1010 in Ulcerative Colitis

Speakers: